Cronos Group Inc traded at 3.91 this Tuesday June 28th, decreasing 0.07 or 1.76 percent since the previous trading session. Looking back, over the last four weeks, Cronos Group Inc lost 4.83 percent. Over the last 12 months, its price fell by 63.70 percent. Looking ahead, we forecast Cronos Group Inc to be priced at 3.94 by the end of this quarter and at 3.68 in one year, according to Trading Economics global macro models projections and analysts expectations.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Peers Price Day Year
Aurora Cannabis Inc 1.93 -0.08 -3.98% -82.89%
British American Tobacco 3,616.50 -11.50 -0.32% 29.16%
Brown Forman Class A 68.70 -0.67 -0.97% -8.78%
Imperial Brands PLC 1,869.00 -4.50 -0.24% 20.04%
Coca-Cola 62.28 -0.63 -1.00% 15.63%
Monster Beverage 90.81 -3.40 -3.61% -0.82%
Altria 43.19 0 0% -7.67%
Philip Morris International 102.44 -0.27 -0.26% 4.59%
Boston Beer 319.17 -14.82 -4.44% -69.15%
Constellation Brands 245.52 -1.90 -0.77% 6.29%
Molson Coors Brewing 55.76 0.38 0.69% 2.44%
Canopy Growth Corp 4.64 -0.25 -5.11% -84.58%

Indexes Price Day Year
CATSX 19223 -35.58 -0.18% -4.70%

Cronos Group Inc
Cronos Group Inc is a cannabinoid company. The Company is focused on cannabis research, technology and product development. The Company’s portfolio includes PEACE NATURALS, COVE, Spinach, Lord Jones and PEACE+. PEACE NATURALS a global wellness platform. The COVE and Spinach are adult-use brands. The Lord Jones and PEACE+ are hemp-derived cannabidiol (CBD) brands. The Company’s segments include United States and Rest of World. The United States segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s subsidiaries include Cronos Israel G.S. Cultivations Ltd, Cronos Israel G.S. Manufacturing Ltd, Cronos Israel G.S. Store Ltd and Cronos Israel G.S. Pharmacies Ltd.